Association between the CYP2E1 polymorphisms and lung cancer risk: a meta-analysis

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Zeitschrift für Induktive Abstammungs- und Vererbungslehre

• Publication date

  2014-10-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00438-014-0941-2PMID 25336053
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epidemiology of Lung Cancer.

  2016cited by this paper
• Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration

  2013cited by this paper
• Polymorphisms in GSTM1, CYP1A1, CYP2E1, and CYP2D6 are Associated with Susceptibility and Chemotherapy Response in Non-small-cell Lung Cancer Patients

  2012cited by this paper
• Cytochrome P450 2E1 RsaI/PstI and DraI polymorphisms are risk factors for lung cancer in Mongolian and Han population in inner Mongolia

  2011cited by this paper
• Cochrane Handbook for Systematic Reviews of Interventions

  2010cited by this paper
• Association between CYP2E1 genetic polymorphisms and lung cancer risk: a meta-analysis.

  2010cited by this paper
• Study on the relationship between genetic polymorphism of human cytochrome P450 2E1 gene and susceptibility to Xuanwei's lung cancer.

  2010cited by this paper
• CYP2E1 Rsa I/Pst I polymorphism is associated with lung cancer risk among Asians.

  2010cited by this paper
• Influence of NQO1, ALDH2, and CYP2E1 genetic polymorphisms, smoking, and alcohol drinking on the risk of lung cancer in Koreans

  2009cited by this paper
• TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies.

  2009cited by this paper
• Effect of combined genetic polymorphisms on lung cancer risk in northern Thai women.

  2009cited by this paper
• Meta- and pooled analysis of GSTP1 polymorphism and lung cancer: a HuGE-GSEC review.

  2009cited by this paper
• Genetic polymorphism and mRNA levels of cytochrome P450IIE1 and glutathione S-transferase P1 in patients with alcoholic liver disease in different nationalities.

  2009cited by this paper
• Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis.

  2008cited by this paper
• Polymorphisms of human N-acetyltransferases and cancer risk.

  2008cited by this paper
• Association between genetic polymorphisms of CYP2E1 and lung cancer susceptibility:a case control study

  2008cited by this paper
• A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers.

  2008cited by this paper
• Susceptibility to lung cancer and genetic polymorphisms in the alcohol metabolite‐related enzymes alcohol dehydrogenase 3, aldehyde dehydrogenase 2, and cytochrome P450 2E1 in the Japanese population

  2007cited by this paper
• Interactive effect of genetic polymorphism of glutathione S-transferase M1 and smoking on squamous cell lung cancer risk in Korea.

  2006cited by this paper
• Association of CYP2E1 polymorphism and serum selenium level with risk of human lung cancer

  2006cited by this paper
• [A case-control study on the impact of cytochrome P450 2E1 and 1A1 gene polymorphisms on the risk of lung can- cer of the Han nationality in Guangzhou district].

  2006cited by this paper
• Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review.

  2006cited by this paper
• NQO1, MPO, and the risk of lung cancer: A HuGE review

  2005cited by this paper
• [Study on the association between genetic polymorphism of CYP2E1, GSTM1 and susceptibility of lung cancer].

  2005cited by this paper
• [The relationship between genetic polymorphism of metabolizing enzymes and the genetic susceptibility to lung cancer].

  2004cited by this paper
• Effect of CYP2E1 Polymorphism on DNA Stability and Lung Cancer Susceptibility

  2004cited by this paper
• Genetic Polymorphisms and Environmental Risk of Lung Cancer: A Review

  2004cited by this paper
• [Studies of the genes related to lung cancer susceptibility in Nanjing Han population, China].

  2004cited by this paper
• [Relationship between genetic polymorphism of metabolizing enzymes and lung cancer susceptibility].

  2004cited by this paper
• Evidence-based prevention (EBP): approach to lung cancer prevention based on cytochrome 1A1 and cytochrome 2E1 polymorphism.

  2003cited by this paper
• Association of GSTM1, CYP1A1 and CYP2E1 genetic polymorphisms with susceptibility to lung adenocarcinoma: A case‐control study in Chinese population

  2003cited by this paper
• Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States)

  2003cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Tobacco use, cancer causation and public health impact

  2002cited by this paper
• Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility.

  2002cited by this paper
• A case-control study of the impact of CYP2E1 RsaI polymorphism on the risk of lung cancer

  2002cited by this paper
• A myeloperoxidase polymorphism associated with reduced risk of lung cancer.

  2002cited by this paper
• Genetic polymorphisms of alcohol metabolizing enzymes.

  2001cited by this paper
• CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people.

  2001cited by this paper
• [Susceptibility to lung cancer in Chinese is associated with genetic polymorphism in cytochrome P4502E1].

  2000cited by this paper
• Relationship between Cytochrome P450 2E1 Genetic Polymorphism and Lung Cancer in Chinese Han Subjects

  2000cited by this paper
• Cytochrome P4502E1 genetic polymorphisms and lung cancer in a Taiwanese population.

  1999cited by this paper
• Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients

  1999cited by this paper
• Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens.

  1998cited by this paper
• Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populations.

  1998cited by this paper
• Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer.

  1997cited by this paper
• Interactions between genetic predisposition and environmental toxicants for development of lung cancer

  1997cited by this paper
• Cytochrome P450 2E1 polymorphism as a risk factor for lung cancer: in relation to p53 gene mutation.

  1997cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Polymorphism of metabolizing genes and lung cancer histology: prevalence of CYP2E1 in adenocarcinoma.

  1997cited by this paper
• Meta-analyses of randomised controlled trials.

  1997cited by this paper
• Meta-analyses of randomised controlled trials.

  1997cited by this paper
• Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes.

  1996cited by this paper
• Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County.

  1996cited by this paper
• Mortality from smoking worldwide.

  1996cited by this paper
• An Rsa I Polymorphism in the CYP2E1 Gene Does Not Affect Lung Cancer Risk in a Japanese Population

  1995cited by this paper
• The heme-binding region polymorphism of cytochrome P450IA1 (CypIA1), rather than the RsaI polymorphism of IIE1 (CypIIE1), is associated with lung cancer in Rio de Janeiro.

  1995cited by this paper
• CYP1A1 and CYP2E1 polymorphism and lung cancer, case-control study in Rio de Janeiro, Brazil.

  1995cited by this paper
• Operating characteristics of a rank correlation test for publication bias.

  1994cited by this paper
• Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer.

  1994cited by this paper
• Epidemiology of lung cancer.

  1994cited by this paper
• Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung.

  1994cited by this paper
• Epidemiology and etiology of lung cancer.

  1993cited by this paper
• The human CYP2E1 gene and lung cancer: DraI and RsaI restriction fragment length polymorphisms in a Finnish study population.

  1993cited by this paper
• Genetic polymorphism of cytochrome P4502E1 in a Swedish population

  1993cited by this paper
• Metabolic cytochrome P450 genotypes and assessment of individual susceptibility to lung cancer.

  1992cited by this paper
• Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk.

  1992cited by this paper
• Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes.

  1992cited by this paper
• Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene.

  1991cited by this paper
• Association between Restriction Fragment Length Polymorphism of the Human Cytochrome P450IIE1 Gene and Susceptibility to Lung Cancer

  1991cited by this paper
• Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke.

  1988cited by this paper
• Meta-analyses of randomized controlled trials.

  1987cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• Nicotine-derived N-nitrosamines and tobacco-related cancer: current status and future directions.

  1985cited by this paper
• The epidemiology and etiology of lung cancer.

  1982cited by this paper
• Statistical aspects of the analysis of data from retrospective studies of disease.

  1959cited by this paper

• Association between CYP2E1 polymorphisms and colorectal cancer risk: a systematic review and meta-analysis

  2022cites this paper
• Investigation of cytochrome P450 inhibitory properties of deoxyshikonin, a bioactive compound from Lithospermum erythrorhizon Sieb. et Zucc

  2022cites this paper
• Cytochromes P450: Role in Carcinogenesis and Relevance to Cancers.

  2022cites this paper
• Inhibition and Induction by Poziotinib of Different Rat Cytochrome P450 Enzymes In Vivo and in an In Vitro Cocktail Method

  2021cites this paper
• Risk assessment of the inhibition of hydroxygenkwanin on human and rat cytochrome P450 by cocktail method.

  2021cites this paper
• Cytochrome P450 2E1 and its roles in disease.

  2020cites this paper
• Evaluation of acacetin inhibition potential against cytochrome P450 in vitro and in vivo.

  2020cites this paper
• Certain interleukin polymorphisms might influence predisposition to lung cancer: A meta‐analysis of 35 published studies

  2020cites this paper
• Associations between Folate Metabolism Enzyme Polymorphisms and Lung Cancer: A Meta-Analysis

  2019cites this paper
• Assessment of interaction between maternal polycyclic aromatic hydrocarbons exposure and genetic polymorphisms on the risk of congenital heart diseases

  2018cites this paper
• Analysis of the role of rs2031920 and rs3813867 polymorphisms within the cytochrome P450 2E1 gene in the risk of squamous cell carcinoma

  2018cites this paper
• Genetic polymorphisms and lung cancer risk: Evidence from meta-analyses and genome-wide association studies.

  2017cites this paper
• Toxicological Implications of Mitochondrial Localization of CYP2E1.

  2017cites this paper
• Evaluation of the inhibition potential of plumbagin against cytochrome P450 using LC-MS/MS and cocktail approach

  2016cites this paper
• Polymorphic Variants of Cytochrome P450: Relevance to Cancer and Other Diseases.

  2015cites this paper
• Genetic polymorphism in HLA-G 3′UTR 14-bp ins/del and risk of cancer: a meta-analysis of case–control study

  2015cites this paper
• Role of Occupational Exposure to Organic Solvents in Lung Cancer Risk : a Multidimensional Analysis in the ICARE Study

  2015cites this paper